How safe are blood, blood products and stem cell preparations? (SARS-CoV-2)
The Paul Ehrlich Institute in Germany has adapted its recommendations for blood and stem cell donation in case of contact with SARS-CoV-2 infected persons. These recommendations thus also apply to SARS-CoV-2 infected women in childbirth and the newborn.
Based on experience with other coronavirus infections (SARS and MERS) and other viruses that lead to respiratory infections, the risk of transfusion-related transmission of SARS-CoV-2 is considered unfounded according to current knowledge. The relevant professional societies in Germany assume that the risk of the newborn being infected with SARS-CoV-2 by the mother is low and the outcome is usually favourable.
Source: Paul Ehrlich Institute (December 2021)
Older age and well-being
Older age and well-being (Prof. Breymann comments on NZZ article from April 8, 2024) It is time that the topic of longevity, with all its sometimes obscure developments, was discussed and addressed seriously ("Eternal healthy life is a false promise", NZZ April 8,...
Read morePerinatal stem cell research: Prof. Breymann in conversation with Famido.ch
This episode is about the fascinating world of stem cell storage from the placenta and umbilical cord. Prof. Breymann, a recognized expert in the field of perinatal stem cell research and pregnancy, discusses the key aspects of this topic with Ms. Isabell Ziegler from famido.ch. In doing so...
Read moreFirst Children's Runway Congress at THE CIRCLE at Zurich Airport (May 25, 2024)
The new "Kinderstartbahn" platform brings together experts from pediatrics and related fields with the common goal of giving children the best possible start in life. Dates: Saturday, May 25, 2024 Location: Circle Convention Center at Zurich Airport. Expert audience and continuing education points Around...
Read more